NYSEMKT:DXR

Daxor Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy DXR

*Your capital is at risk

$10.50

-0.345 (-3.18%)

At Close: Jul 31, 2026

Daxor Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 377.57K and sold 0 DXR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	377.57K shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 06, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Jonathan Adam Chief Scientific Officer	Officer	32 000 Value: $284.5K
Jul 15, 2024 Buy	Stock options (right to buy) A-Award	Desrosiers Caleb Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Goudie Joy S. Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Feuer Edward Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Cremisi Henry D. Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Cremisi Henry D. Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Feuer Edward Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock Options (right to buy) A-Award	Goudie Joy S. Director	Director	2 500 Value: $23.0K
Jul 15, 2024 Buy	Stock options (right to buy) A-Award	Desrosiers Caleb Director	Director	2 500 Value: $23.0K
Mar 27, 2024 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	750 Value: $7K
Mar 27, 2024 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	750 Value: $7K
Mar 26, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Office	Officer	1 000 Value: $8K
Mar 26, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Office	Officer	1 000 Value: $8K
Mar 19, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Officer	CEO / President	647 Value: $5K
Mar 19, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Officer	CEO / President	647 Value: $5K
Mar 10, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Officer	CEO / President	1 492 Value: $11.5K
Mar 10, 2024 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Officer	CEO / President	1 492 Value: $11.5K
Mar 04, 2024 Buy	Daxor Common Stock P-Purchase	Feuer Edward Director	Director	1 000 Value: $7K
Mar 04, 2024 Buy	Daxor Common Stock P-Purchase	Feuer Edward Director	Director	1 000 Value: $7K
Dec 06, 2023 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	120 Value: $930
Dec 06, 2023 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	120 Value: $930
Dec 01, 2023 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	180 Value: $1K
Dec 01, 2023 Buy	Daxor Common Stock P-Purchase	Feldschuh Michael Richard Chief Executive Officer	CEO / President	800 Value: $6K
Mar 27, 2023 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	4 750 Value: $0
Mar 27, 2023 Buy	Daxor Common Stock P-Purchase	Michel Robert J Chief Financial Officer	C-Suite Officer	4 750 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT DAXOR CORP

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation...

Read Full Profile Here